Are you ready for Congress’ “Wealth Transfer Act”?

From Legacy Research | Ad

The mainstream media will NOT cover this story… But luckily Teeka Tiwari is revealing all the details of this terrifying new bill that’s working its way through Congress.

He’ll even give away the name and ticker of his #1 investment for this new trend.

Click here to see his #1 investment

RPRX Insider Trading (Royalty Pharma)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 25.86%

Insider Buying (Last 12 Months): $1,203,531.00

Insider Selling (Last 12 Months): $400,110,444.91

Royalty Pharma Insider Trading History Chart

Royalty Pharma Share Price & Price History

^$38.50

▲ +0.12 (0.31%)

As of 09/17/2021 05:00 PM ET

Days: 30 | 90 | 365

Veteran Tech Legend: “Biggest Investing Event in 400 Years”

From Legacy Research | Ad

He called the #1-returning tech stocks of 2016, 2018, 2019, AND 2020… Now America’s forecasting legend Jeff Brown declares:

“Nobody is paying attention to this technology…

But it’s about to change the types of houses, cars & investments you can own (and profit from)… In a way, we haven’t seen for 400+ years.”

[VIDEO]: How Just $25 Cuts You In

Royalty Pharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/26/2021	George W. Lloyd	EVP	Sell	13,362	$39.78	$531,540.36
7/14/2021	James F Reddoch	EVP	Sell	2	$42.00	$84.00
7/12/2021	George W. Lloyd	EVP	Sell	100	$42.04	$4,204.00	3,000
7/8/2021	James F. Reddoch	EVP	Sell	40,655	$42.05	$1,709,542.75	3,000
7/6/2021	James F. Reddoch	EVP	Sell	30,270	$42.40	$1,283,448.00	3,000
6/28/2021	Rory B Riggs	Director	Sell	167,448	$42.11	$7,051,235.28	679,760
6/25/2021	Rory B Riggs	Director	Sell	666,464	$42.72	$28,471,342.08	679,760
6/10/2021	George W. Lloyd	EVP	Sell	70,000	$46.49	$3,254,300.00	3,000
6/7/2021	Marshall Urist	EVP	Sell	16,568	$47.02	$779,027.36	16,568
6/4/2021	Marshall Urist	EVP	Sell	16,566	$45.13	$747,623.58	16,568
6/2/2021	Marshall Urist	EVP	Sell	14,566	$41.52	$604,780.32
4/14/2021	George W. Lloyd	EVP	Sell	69,822	$42.13	$2,941,600.86	3,000
4/12/2021	George W. Lloyd	EVP	Sell	449	$42.32	$19,001.68	3,000
3/22/2021	James F Reddoch	EVP	Sell	43,927	$46.32	$2,034,698.64	3,000
3/2/2021	George W. Lloyd	EVP	Sell	125,000	$46.94	$5,867,500.00	3,000
3/2/2021	Terrance P Coyne	CFO	Sell	100,000	$46.94	$4,694,000.00	1,500
2/25/2021	Henry A Fernandez	Director	Buy	25,700	$46.83	$1,203,531.00	8,713
12/18/2020	Adage Capital Partners Gp, L.L	Major Shareholder	Sell	7,301,050	$43.92	$320,662,116.00
10/20/2020	Rory B Riggs	Director	Sell	463,200	$42.00	$19,454,400.00	463,200
6/18/2020	Adage Capital Partners Gp, L.L	Major Shareholder	Buy	3,000,000	$28.00	$84,000,000.00
6/18/2020	George W. Lloyd	EVP	Buy	3,000	$28.00	$84,000.00	3,000
6/18/2020	Pablo G Legorreta	CEO	Buy	20,000	$28.00	$560,000.00
6/18/2020	Terrance P Coyne	CFO	Buy	1,500	$28.00	$42,000.00	1,500
6/18/2020	William E Ford	Director	Buy	1,500,000	$28.00	$42,000,000.00

Insider Selling at Royalty Pharma?

Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Royalty Pharma and related companies.

SEC Filings (Institutional Ownership Changes) for Royalty Pharma (NASDAQ:RPRX)

40.55% of Royalty Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Royalty Pharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/17/2021	Virtu Financial LLC	23,827	$0.98M	0.1%	N/A	0.004%
9/13/2021	Bank of America Corp DE	1,592,556	$65.28M	0.0%	+11.7%	0.262%
9/3/2021	Parametric Portfolio Associates LLC	239,517	$9.82M	0.0%	+30.4%	0.039%
8/26/2021	Comerica Bank	9,151	$0.36M	0.0%	-4.8%	0.002%
8/17/2021	Wells Fargo & Company MN	106,124	$4.35M	0.0%	+196.0%	0.017%
8/17/2021	Worldquant Millennium Advisors LLC	115,229	$4.72M	0.1%	N/A	0.019%
8/17/2021	Invesco Ltd.	693,518	$28.43M	0.0%	+4.7%	0.114%
8/17/2021	Price T Rowe Associates Inc. MD	2,199,853	$90.17M	0.0%	-6.6%	0.362%
8/17/2021	Prudential Financial Inc.	9,865	$0.40M	0.0%	+20.0%	0.002%
8/17/2021	Caas Capital Management LP	619,939	$25.41M	0.4%	-54.8%	0.102%
8/17/2021	Canada Pension Plan Investment Board	995	$41K	0.0%	-99.3%	0.000%
8/16/2021	Squarepoint Ops LLC	176,152	$7.22M	0.0%	+1,108.0%	0.029%
8/16/2021	Bank of America Corp DE	1,592,556	$65.28M	0.0%	+11.7%	0.262%
8/16/2021	UBS Asset Management Americas Inc.	573,435	$23.51M	0.0%	+10.7%	0.094%
8/16/2021	FORA Capital LLC	14,877	$0.61M	0.1%	N/A	0.002%
8/16/2021	Cubist Systematic Strategies LLC	212,488	$8.71M	0.1%	+451.8%	0.035%
8/16/2021	Glenmede Trust Co. NA	22,366	$0.92M	0.0%	-25.1%	0.004%
8/16/2021	California State Teachers Retirement System	571,384	$23.42M	0.0%	-0.5%	0.094%
8/16/2021	Occudo Quantitative Strategies LP	71,925	$2.95M	0.5%	+98.8%	0.012%
8/16/2021	Capital International Inc. CA	838,074	$34.35M	0.3%	-6.4%	0.138%
8/16/2021	Alyeska Investment Group L.P.	351,597	$14.41M	0.2%	+7.7%	0.058%
8/16/2021	First Trust Advisors LP	487,022	$19.96M	0.0%	-9.8%	0.080%
8/16/2021	Public Employees Retirement System of Ohio	186,071	$7.63M	0.0%	+8.3%	0.031%
8/16/2021	Capital International Investors	16,942,708	$694.48M	0.2%	+3.0%	2.791%
8/16/2021	Royal Bank of Canada	354,735	$14.54M	0.0%	+166.8%	0.058%
8/16/2021	Formidable Asset Management LLC	16,560	$0.66M	0.1%	N/A	0.003%
8/16/2021	Morgan Stanley	50,794,041	$2.08B	0.3%	+5.6%	8.366%
8/16/2021	Amundi	2,828,265	$115.93M	0.1%	N/A	0.466%
8/16/2021	Credit Suisse AG	150,884	$6.19M	0.0%	+30.1%	0.025%
8/16/2021	Schonfeld Strategic Advisors LLC	64,200	$2.63M	0.0%	-39.5%	0.011%
8/16/2021	Charles Schwab Investment Management Inc.	265,825	$10.90M	0.0%	+8.4%	0.044%
8/16/2021	Andra AP fonden	130,100	$5.33M	0.1%	+29.7%	0.021%
8/16/2021	State Street Corp	4,867,634	$199.52M	0.0%	+3.9%	0.802%
8/16/2021	Nuveen Asset Management LLC	1,194,882	$48.98M	0.0%	-0.3%	0.197%
8/16/2021	M&T Bank Corp	12,791	$0.52M	0.0%	+4.3%	0.002%
8/16/2021	Allianz Asset Management GmbH	10,223	$0.42M	0.0%	+106.0%	0.002%
8/13/2021	Harvard Management Co. Inc.	7,142,856	$292.79M	16.8%	-33.3%	1.177%
8/13/2021	Renaissance Technologies LLC	828,600	$33.96M	0.0%	N/A	0.136%
8/13/2021	Northern Trust Corp	1,218,491	$49.95M	0.0%	-6.7%	0.201%
8/13/2021	Laurion Capital Management LP	21,347	$0.88M	0.0%	-57.3%	0.004%
8/13/2021	Virginia Retirement Systems ET AL	18,300	$0.75M	0.0%	N/A	0.003%
8/13/2021	Toroso Investments LLC	5,960	$0.24M	0.0%	N/A	0.001%
8/13/2021	APG Asset Management N.V.	15,311	$0.53M	0.0%	+4.5%	0.003%
8/13/2021	California Public Employees Retirement System	715,172	$29.32M	0.0%	-5.2%	0.118%
8/13/2021	Philadelphia Trust Co.	173,025	$7.09M	0.5%	+0.3%	0.028%
8/13/2021	Franklin Resources Inc.	414,553	$16.99M	0.0%	-63.0%	0.068%
8/13/2021	Bridgewater Associates LP	18,347	$0.75M	0.0%	N/A	0.003%
8/13/2021	Overbrook Management Corp	757,121	$31.03M	6.5%	-1.8%	0.125%
8/13/2021	Blueshift Asset Management LLC	44,712	$1.83M	0.1%	+694.5%	0.007%
8/13/2021	Ensign Peak Advisors Inc	2,530	$0.10M	0.0%	-92.1%	0.000%
8/13/2021	Elo Mutual Pension Insurance Co	12,398	$0.51M	0.0%	-3.0%	0.002%
8/13/2021	Qube Research & Technologies Ltd	86,946	$3.56M	0.0%	N/A	0.014%
8/13/2021	Geode Capital Management LLC	1,984,686	$81.22M	0.0%	+2.8%	0.327%
8/13/2021	Vanguard Group Inc.	24,342,200	$997.79M	0.0%	+8.1%	4.010%
8/13/2021	FMR LLC	24,095,929	$987.69M	0.1%	-13.8%	3.969%
8/13/2021	ProShare Advisors LLC	73,712	$3.02M	0.0%	+33.3%	0.012%
8/12/2021	Trexquant Investment LP	9,223	$0.38M	0.0%	-71.0%	0.002%
8/12/2021	Profund Advisors LLC	7,439	$0.31M	0.0%	+11.3%	0.001%
8/12/2021	Edgewood Management LLC	43,000	$1.76M	0.0%	-55.4%	0.007%
8/12/2021	Wellington Shields & Co. LLC	91,170	$3.74M	1.2%	-2.7%	0.015%
8/12/2021	Healthcare of Ontario Pension Plan Trust Fund	281,774	$11.55M	0.0%	+5,598.2%	0.046%
8/12/2021	Dimensional Fund Advisors LP	9,146	$0.38M	0.0%	-3.1%	0.002%
8/12/2021	Oxler Private Wealth LLC	6,570	$0.27M	0.1%	N/A	0.001%
8/12/2021	SG Americas Securities LLC	11,474	$0.47M	0.0%	-66.6%	0.002%
8/12/2021	State of Wisconsin Investment Board	104,624	$4.29M	0.0%	-3.2%	0.017%
8/12/2021	qPULA Trading Management LP	5,000	$0.21M	0.4%	N/A	0.001%
8/12/2021	Legal & General Group Plc	1,471,237	$60.31M	0.0%	+4.9%	0.242%
8/12/2021	JPMorgan Chase & Co.	7,315,001	$299.84M	0.0%	+26.2%	1.205%
8/12/2021	Bank of Montreal Can	125,379	$5.16M	0.0%	+1.6%	0.021%
8/12/2021	The Manufacturers Life Insurance Company	134,781	$5.53M	0.0%	-30.3%	0.022%
8/12/2021	Fjarde AP Fonden Fourth Swedish National Pension Fund	62,200	$2.55M	0.0%	-6.7%	0.010%
8/12/2021	Mitsubishi UFJ Trust & Banking Corp	104,277	$4.29M	0.0%	-3.2%	0.017%
8/12/2021	Xponance Inc.	24,172	$0.99M	0.0%	+68.1%	0.004%
8/11/2021	Bank of New York Mellon Corp	993,306	$40.72M	0.0%	+16.4%	0.164%
8/11/2021	BlackRock Inc.	10,287,641	$421.69M	0.0%	-24.7%	1.695%
8/11/2021	Deutsche Bank AG	243,908	$10M	0.0%	+38.8%	0.040%
8/11/2021	Aurora Investment Counsel	22,797	$0.93M	0.7%	N/A	0.004%
8/11/2021	Vantage Consulting Group Inc	9,302,445	$381.31M	66.3%	+6.9%	1.532%
8/11/2021	Panagora Asset Management Inc.	13,861	$0.57M	0.0%	-10.6%	0.002%
8/11/2021	Banque Cantonale Vaudoise	8,300	$0.34M	0.0%	N/A	0.001%
8/11/2021	Westpac Banking Corp	19,492	$0.80M	0.0%	N/A	0.003%
8/10/2021	abrdn plc	1,884,011	$77.24M	0.2%	+6,482.2%	0.310%
8/10/2021	World Asset Management Inc	5,141	$0.21M	0.0%	-7.3%	0.001%
8/10/2021	Principal Financial Group Inc.	31,723	$1.30M	0.0%	+13.9%	0.005%
8/10/2021	Ethic Inc.	6,638	$0.27M	0.0%	N/A	0.001%
8/10/2021	Aviva PLC	103,879	$4.26M	0.0%	+1.5%	0.017%
8/10/2021	State Board of Administration of Florida Retirement System	243,550	$9.98M	0.0%	+15.7%	0.040%
8/10/2021	Citigroup Inc.	117,645	$4.82M	0.0%	-28.8%	0.019%
8/10/2021	Rockefeller Capital Management L.P.	15,576	$0.64M	0.0%	+24.6%	0.003%
8/10/2021	Rafferty Asset Management LLC	11,213	$0.46M	0.0%	+37.5%	0.002%
8/10/2021	WINTON GROUP Ltd	54,910	$2.25M	0.1%	N/A	0.009%
8/9/2021	TimesSquare Capital Management LLC	1,501,560	$61.55M	0.5%	+6.1%	0.247%
8/9/2021	BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp	32,356	$1.33M	0.0%	+13.0%	0.005%
8/6/2021	HighTower Advisors LLC	118,407	$4.85M	0.0%	N/A	0.020%
8/6/2021	Daiwa Securities Group Inc.	16,580	$0.68M	0.0%	+6.5%	0.003%
8/6/2021	Nomura Asset Management Co. Ltd.	77,299	$3.17M	0.0%	-46.0%	0.013%
8/6/2021	Sei Investments Co.	126,418	$5.15M	0.0%	+35.5%	0.021%
8/6/2021	Teza Capital Management LLC	5,461	$0.22M	0.0%	N/A	0.001%
8/6/2021	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	36,336	$1.49M	0.0%	-0.8%	0.006%
8/6/2021	Swiss National Bank	714,510	$29.29M	0.0%	+6.4%	0.118%

Data available starting January 2016

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio includes royalties on approximately 45 commercial products and 5 development-stage product candidates in various therapeutic areas, such as rare disease, oncology, neurology, infectious disease, cardiology, and diabetes. The company has royalties on various product, such as Cystic fibrosis franchise, including Kalydeco, Orkambi, Symdeko/Symkevi, and Trikafta/Kaftrio; HIV franchise comprising Atripla, Truvada, Emtriva, Complera, Stribild, Genvoya, Descovy, Odefsey, Symtuza, and Biktarvy; Tradjenta, Onglyza, Kombiglyze, Galvus, Eucreas, and Nesina; Tysabri, Imbruvica, Xtandi, Promacta, Farxiga/Onglyza, Prevymis, Emgality, Crysvita, Erleada, IDHIFA, Trodelvy, Nurtec ODT, Tazverik, and Evrysdi; and other products, such as Bosulif, Cimzia, Conbriza/Fablyn/Viviant, Entyvio, Lexiscan, Mircera, Myozyme, Nesina, Priligy, and Soliqua, as well as Tecfidera, Letairis, Lyrica, Remicade, Humira, Prezista, Rotateq, and Thalomid. Royalty Pharma plc was founded in 1996 and is based in New York, New York.

Today's Range

Now: $38.50

$38.01

$38.95

50 Day Range

MA: $38.90

$36.43

$41.77

52 Week Range

Now: $38.50

$34.80

$53.23

Volume

17,928,213 shs

Average Volume

2,285,057 shs

Market Capitalization

$23.38 billion

P/E Ratio

24.06

Dividend Yield

1.77%

Beta

Who are the company insiders with the largest holdings of Royalty Pharma?

Royalty Pharma's top insider shareholders include:

Rory B Riggs (Director)
Marshall Urist (EVP)
Henry A Fernandez (Director)
George W Lloyd (EVP)
James F Reddoch (EVP)
Terrance P Coyne (CFO)
Adage Capital Partners Gp, LL (Major Shareholder)
Pablo G Legorreta (CEO)
Sanjay Kumar Singh (CRO)
Scientific Corp Boston (Major Shareholder)
William E Ford (Director)

Who are the major institutional investors of Royalty Pharma?

Royalty Pharma's top institutional investors include:

Morgan Stanley — 8.37%
Vanguard Group Inc. — 4.01%
FMR LLC — 3.97%
Capital International Investors — 2.79%
BlackRock Inc. — 1.69%
Vantage Consulting Group Inc — 1.53%

Which major investors are selling Royalty Pharma stock?

During the last quarter, RPRX stock was sold by these institutional investors:

FMR LLC
Harvard Management Co. Inc.
BlackRock Inc.
Victory Capital Management Inc.
Caas Capital Management LP
Franklin Resources Inc.
Price T Rowe Associates Inc. MD
Canada Pension Plan Investment Board

During the last year, company insiders that have sold Royalty Pharma company stock include:

Rory B Riggs (Director)
Marshall Urist (EVP)
Henry A Fernandez (Director)
George W Lloyd (EVP)
James F Reddoch (EVP)
Terrance P Coyne (CFO)
Adage Capital Partners Gp, LL (Major Shareholder)
Pablo G Legorreta (CEO)

Which major investors are buying Royalty Pharma stock?

Within the last quarter, RPRX stock was bought by institutional investors including:

Amundi
Morgan Stanley
abrdn plc
Vanguard Group Inc.
JPMorgan Chase & Co.
Renaissance Technologies LLC
RE Advisers Corp
Vantage Consulting Group Inc

In the last year, these company insiders have bought Royalty Pharma stock:

Rory B Riggs (Director)
Marshall Urist (EVP)
Henry A Fernandez (Director)
George W Lloyd (EVP)
James F Reddoch (EVP)
Terrance P Coyne (CFO)

Man Who Predicted Bitcoin Says "This is Bigger"

From Legacy Research | Ad

He called Tesla in 2018... and Bitcoin in 2015... now he says a brand-new financial technology could unleash a Quadrillion-dollar impact starting 2021.

Learn More Here!